Kasim Vivi, Xie Yu-Dan, Wang Hui-Min, Huang Can, Yan Xue-Song, Nian Wei-Qi, Zheng Xiao-Dong, Miyagishi Makoto, Wu Shou-Rong
The Key Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University, Chongqing, China.
The 111 Project Laboratory of Biomechanics and Tissue Repair, College of Bioengineering, Chongqing University, Chongqing, China.
Oncotarget. 2017 May 19;8(33):54694-54707. doi: 10.18632/oncotarget.18005. eCollection 2017 Aug 15.
Yin Yang 2 (YY2) is a multifunctional zinc-finger transcription factor that belongs to YY family. Unlike the well-characterized YY1, our understanding regarding the biological functions of YY2 is still very limited. Here we found for the first time that in contrast to YY1, which had been reported to be oncogenic, the expression level of YY2 in tumor cells and/or tissues was downregulated compared with its expression level in the normal ones. We also demonstrated that YY2 exerts biological function contrary to YY1 in cell proliferation. We elucidated that YY2 positively enhances p21 expression, and concomitantly, its silencing promotes cells to enter G2/M phase and enhances cell proliferation. Furthermore, we found that YY2 regulation on p21 occurs p53-dependently. Finally, we identified a novel YY2 binding site in the promoter region of tumor suppressor p53. We found that YY2 binds to the p53 promoter and activates its transcriptional activity, and subsequently, regulates cell cycle progression via p53/p21 axis. Taken together, our study not only identifies YY2 as a novel tumor suppressor gene that plays a pivotal role in cell cycle regulation, but also provides new insights regarding the regulatory mechanism of the conventional p53/p21 axis.
阴阳2(YY2)是一种多功能锌指转录因子,属于YY家族。与已被充分研究的YY1不同,我们对YY2生物学功能的了解仍然非常有限。在这里,我们首次发现,与据报道具有致癌性的YY1相反,肿瘤细胞和/或组织中YY2的表达水平与其在正常细胞和组织中的表达水平相比下调。我们还证明,YY2在细胞增殖方面发挥着与YY1相反的生物学功能。我们阐明,YY2正向增强p21的表达,同时,其沉默促进细胞进入G2/M期并增强细胞增殖。此外,我们发现YY2对p21的调节是依赖p53的。最后,我们在肿瘤抑制因子p53的启动子区域鉴定出一个新的YY2结合位点。我们发现YY2与p53启动子结合并激活其转录活性,随后通过p53/p21轴调节细胞周期进程。综上所述,我们的研究不仅将YY2鉴定为一种在细胞周期调节中起关键作用的新型肿瘤抑制基因,还为传统p53/p21轴的调控机制提供了新的见解。